Astrana Health, Inc. (NASDAQ:ASTH) Given Average Recommendation of “Moderate Buy” by Brokerages

Shares of Astrana Health, Inc. (NASDAQ:ASTH) have been assigned a consensus rating of “Moderate Buy” from the nine brokerages that are covering the firm, MarketBeat.com reports. Three investment analysts have rated the stock with a hold recommendation and six have given a buy recommendation to the company. The average 1-year price target among analysts that have updated their coverage on the stock in the last year is $43.1429.

ASTH has been the topic of a number of recent analyst reports. Barclays raised their target price on Astrana Health from $26.00 to $37.00 and gave the stock an “equal weight” rating in a report on Monday, May 11th. Robert W. Baird set a $45.00 target price on Astrana Health in a report on Friday, May 8th. Zacks Research upgraded Astrana Health from a “strong sell” rating to a “hold” rating in a report on Wednesday, March 11th. TD Cowen raised their target price on Astrana Health from $35.00 to $45.00 and gave the stock a “buy” rating in a report on Tuesday, May 12th. Finally, Weiss Ratings upgraded Astrana Health from a “sell (d+)” rating to a “hold (c-)” rating in a report on Wednesday, April 29th.

Astrana Health Price Performance

Shares of ASTH opened at $38.26 on Monday. The company has a current ratio of 1.35, a quick ratio of 1.35 and a debt-to-equity ratio of 1.20. Astrana Health has a 1 year low of $18.08 and a 1 year high of $39.93. The stock has a market cap of $2.13 billion, a P/E ratio of 62.72 and a beta of 0.98. The stock’s 50-day moving average price is $29.30 and its two-hundred day moving average price is $25.91.

Astrana Health (NASDAQ:ASTH) last issued its earnings results on Thursday, May 7th. The company reported $0.74 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.29 by $0.45. Astrana Health had a return on equity of 9.22% and a net margin of 0.86%.The firm had revenue of $965.10 million for the quarter, compared to analysts’ expectations of $949.21 million. During the same quarter last year, the business earned $0.42 earnings per share. The company’s revenue was up 55.6% compared to the same quarter last year. On average, equities analysts predict that Astrana Health will post 1.25 earnings per share for the current year.

Institutional Investors Weigh In On Astrana Health

A number of hedge funds have recently modified their holdings of the business. Quantinno Capital Management LP raised its position in shares of Astrana Health by 69.4% during the first quarter. Quantinno Capital Management LP now owns 64,509 shares of the company’s stock worth $1,582,000 after purchasing an additional 26,418 shares during the period. Renaissance Technologies LLC raised its position in shares of Astrana Health by 12.2% during the first quarter. Renaissance Technologies LLC now owns 104,546 shares of the company’s stock worth $2,563,000 after purchasing an additional 11,400 shares during the period. Sei Investments Co. raised its position in shares of Astrana Health by 94.4% during the first quarter. Sei Investments Co. now owns 134,899 shares of the company’s stock worth $3,308,000 after purchasing an additional 65,509 shares during the period. Cetera Investment Advisers raised its position in shares of Astrana Health by 15.4% during the first quarter. Cetera Investment Advisers now owns 21,430 shares of the company’s stock worth $525,000 after purchasing an additional 2,863 shares during the period. Finally, First Citizens Bank & Trust Co. raised its position in shares of Astrana Health by 48.3% during the first quarter. First Citizens Bank & Trust Co. now owns 16,614 shares of the company’s stock worth $407,000 after purchasing an additional 5,408 shares during the period. Institutional investors and hedge funds own 52.77% of the company’s stock.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans.